tiprankstipranks
Novo Nordisk kidney failure only ‘modest negative,’ says BMO Capital
PremiumThe FlyNovo Nordisk kidney failure only ‘modest negative,’ says BMO Capital
6d ago
Novo Nordisk stops CLARION-CKD trial, recognizes DKK 5.7B impairment loss
PremiumThe Fly
Novo Nordisk stops CLARION-CKD trial, recognizes DKK 5.7B impairment loss
6d ago
Novo Nordisk’s FLOW data supportive of ‘growing moat’, says BMO Capital
PremiumThe Fly
Novo Nordisk’s FLOW data supportive of ‘growing moat’, says BMO Capital
7d ago
Novo Nordisk Launches Multibillion Share Buyback
PremiumCompany AnnouncementsNovo Nordisk Launches Multibillion Share Buyback
8d ago
Novo Nordisk says Mim8 demonstrated superior reductions in ABR in trial
PremiumThe Fly
Novo Nordisk says Mim8 demonstrated superior reductions in ABR in trial
9d ago
WHO issues warning on falsified semaglutides
PremiumThe Fly
WHO issues warning on falsified semaglutides
12d ago
Novo Nordisk Launches Major Share Buyback
PremiumCompany AnnouncementsNovo Nordisk Launches Major Share Buyback
22d ago
Novo Nordisk price target raised to $160 from $125 at Argus
PremiumThe Fly
Novo Nordisk price target raised to $160 from $125 at Argus
22d ago
Novo Nordisk Launches Major Share Buyback Plan
PremiumCompany Announcements
Novo Nordisk Launches Major Share Buyback Plan
29d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100